SMS Lifesciences India Limited (SMSLIFE.BO)
INR 1176.0
(0.0%)
INR 1176.0
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 180.9 Million | 146.95 Million | -112.41 Million | 351.69 Million | 145.46 Million | 299.92 Million |
| Net Income | 90.92 Million | 142.41 Million | 200.38 Million | 195.67 Million | 146.68 Million | 253.84 Million |
| Depreciation & Amortization | 149.37 Million | 107.88 Million | 100.06 Million | 78.61 Million | 78.61 Million | 63.8 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -40.26 Million | -121.53 Million | -376.23 Million | 101.6 Million | -82.98 Million | 19.38 Million |
| Other non-cash items | 284.92 Million | 18.18 Million | -36.62 Million | -24.19 Million | 3.15 Million | -37.11 Million |
| Investing Cash Flow | -184.12 Million | -312.91 Million | -71.42 Million | -262.34 Million | -270.19 Million | -440.1 Million |
| Investments in PPE | -208.67 Million | -485.5 Million | -511.53 Million | -355.56 Million | -233.53 Million | -244.17 Million |
| Acquisitions | 1.22 Million | 57.51 Million | 96.35 Million | 867 Thousand | 1.32 Million | 1.23 Million |
| Investment purchases | - | -1.17 Million | 2.11 Million | -20.19 Million | -38 Million | -209.72 Million |
| Sales/Maturities of investments | 23.32 Million | 111.96 Million | 337.86 Million | 38.07 Million | 383 Thousand | 12.51 Million |
| Other Investing Activities | -1.15 Million | 4.28 Million | 3.76 Million | 74.46 Million | -363 Thousand | 49 Thousand |
| Financing Cash Flow | -2.7 Million | 168.88 Million | 108.33 Million | -25.46 Million | 124.45 Million | 153.67 Million |
| Debt repayment | -1.83 Million | -114.36 Million | -73.14 Million | -62.66 Million | -84.51 Million | -70.14 Million |
| Dividends payments | -4.53 Million | -4.53 Million | -4.53 Million | - | -5.46 Million | -14.18 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 1000.00 | 287.78 Million | 186.01 Million | 37.2 Million | 214.43 Million | 238 Million |
| Accounts receivables | -53.37 Million | -127.42 Million | 1.05 Million | -120.58 Million | 203.48 Million | -115.28 Million |
| Accounts payables | -2.17 Million | -181.16 Million | 173.57 Million | 170.1 Million | -501.16 Million | 497.36 Million |
| Inventory | 50.24 Million | -2.8 Million | -241.95 Million | 26.66 Million | 169.49 Million | -304.4 Million |
| Other working capital | -34.95 Million | 189.85 Million | -308.9 Million | 25.41 Million | 45.19 Million | -58.28 Million |
| Cash at beginning of period | 20.8 Million | 9.86 Million | 85.36 Million | 21.47 Million | 21.74 Million | 8.24 Million |
| Cash at end of period | 14.92 Million | 12.77 Million | 9.86 Million | 85.36 Million | 21.47 Million | 21.74 Million |
| Capital Expenditure | -208.67 Million | -485.5 Million | -511.53 Million | -355.56 Million | -233.53 Million | -244.17 Million |
| Effect of forex changes on cash | - | - | - | - | - | -1000.00 |
| Net cash flow / Change in cash | -5.88 Million | 2.91 Million | -75.5 Million | 63.88 Million | -270 Thousand | 13.5 Million |
| Free Cash Flow | -27.77 Million | -338.55 Million | -623.94 Million | -3.86 Million | -88.06 Million | 55.74 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 69.98 Million | 59.04 Million | 90.92 Million | 43.04 Million | 6.66 Million | -17.95 Million |
| Depreciation & Amortization | - | - | 149.37 Million | 37.25 Million | 37.34 Million | 36.95 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | -40.26 Million | - | - | - |
| Other non-cash items | -69.98 Million | -59.04 Million | 284.92 Million | -43.04 Million | -6.66 Million | 17.95 Million |
| Investing Cash Flow | - | - | -184.12 Million | - | - | - |
| Investments in PPE | - | - | -208.67 Million | - | - | - |
| Acquisitions | - | - | 1.22 Million | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 23.32 Million | - | - | - |
| Other Investing Activities | - | - | -1.15 Million | - | - | - |
| Financing Cash Flow | - | - | -2.7 Million | - | - | - |
| Debt repayment | - | - | -1.83 Million | - | - | - |
| Dividends payments | - | - | -4.53 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | 1000.00 | - | - | - |
| Accounts receivables | - | - | -53.37 Million | - | - | - |
| Accounts payables | - | - | -2.17 Million | - | - | - |
| Inventory | - | - | 50.24 Million | - | - | - |
| Other working capital | - | - | -34.95 Million | - | - | - |
| Cash at beginning of period | - | - | 20.8 Million | 19.56 Million | 12.9 Million | 20.8 Million |
| Cash at end of period | - | - | 14.92 Million | 43.03 Million | 19.56 Million | -17.95 Million |
| Capital Expenditure | - | - | -208.67 Million | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | -5.88 Million | 23.47 Million | 6.66 Million | -38.75 Million |
| Free Cash Flow | - | - | -27.77 Million | 43.03 Million | 6.66 Million | -17.95 Million |
UCAR
OXLC
ITIM
GYM
300582
BFIT